Investors are glued to Eli Lilly (LLY) shares this morning as the pharmaceutical behemoth became the world’s first trillion-dollar healthcare company. LLY has soared this year on the back of explosive demand for its obesity (Zepbound) and diabetes (Mounjaro) treatments, which together brought in over $10 billion in the company’s latest reported quarter. More News from Barchart At the time of writing, Eli Lilly stock is up a whopping 70% versus its low in early August. www.barchart.com How High Can Eli ...